The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Knowing what to include in a beginner investment portfolio is vital for success. Learn the key elements to make informed investment choices.
22,477 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
U.S. prosecutors in New York investigate links between Colombia's president and drug traffickers, while the DEA desig...
Circle Internet Group stock has tumbled amid regulatory whispers around stablecoins. This guide breaks down what the ...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
The U.K. edition of Saturday Night Live is renewed for a second season, underscoring a new model where social-clip vi...
Alphabet appears to be closing the gap with Nvidia in market value as AI-enabled services, search and cloud growth bo...
Investing in niche space stocks can be volatile. This analysis breaks down why gilat satellite networks stock dropped...
Inflation soaring again, this under-the-radar ETF is quietly drawing interest from investors seeking an edge against ...
New long-term care products now let many baby boomers access coverage without underwriting, signaling a shift in reti...
Nvidia’s quarterly print arrives amid an AI demand cycle that remains uneven. Analysts say nvidia earnings don’t matt...
Five years after a regulatory shock hit XRP, a $10,000 investment would have swung through a volatile ride. Here’s th...
A lot of beaten-down SaaS names have bounced recently. This guide explains how to tell if the rise this beaten-down s...